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Abstract
Background: Chronic pain is common, often widespread and has a substantial impact on health and quality of life. The
relationship between chronic pain and mortality is unclear. This systematic review aimed to identify and evaluate evidence
for a relationship between chronic pain and mortality.
Methods: A search of ten electronic databases including EMBASE and MEDLINE was conducted in March 2012, and updated
until March 2014. Observational studies investigating the association between chronic or widespread pain (including
fibromyalgia) and mortality were included. Risk of bias was assessed and a meta-analysis was undertaken to quantify
heterogeneity and pool results. A narrative review was undertaken to explore similarities and differences between the
included studies.
Results: Ten studies were included in the review. Three reported significant associations between chronic or widespread
pain and mortality in unadjusted results. In adjusted analyses, four studies reported a significant association. The remaining
studies reported no statistically significant association. A meta-analysis showed statistically significant heterogeneity of
results from studies using comparable outcome measures (n = 7)(I2 = 78.8%) and a modest but non-significant pooled
estimate (MRR1.14,95%CI 0.95–1.37) for the relationship between chronic pain and all-cause mortality. This association was
stronger when analysis was restricted to studies of widespread pain (n = 5,I2 = 82.3%) MRR1.22(95%CI 0.93–1.60). The same
pattern was observed with deaths from cancer and cardiovascular diseases. Heterogeneity is likely to be due to differences
in study populations, follow-up time, pain phenotype, methods of analysis and use of confounding factors.
Conclusion: This review showed a mildly increased risk of death in people with chronic pain, particularly from cancer.
However, the small number of studies and methodological differences prevented clear conclusions from being drawn.
Consistently applied definitions of chronic pain and further investigation of the role of health, lifestyle, social and
psychological factors in future studies will improve understanding of the relationship between chronic pain and mortality.
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Introduction
Musculoskeletal pain is one of the most common complaints in
adults [1]. It has a major impact on physical and mental health,
daily activities and is a frequent reason for health care consultation
[2–4]. Musculoskeletal pain may be associated with increased
mortality although the relationship is unclear. Studies of single site
pain (e.g. back pain [5,6]), hip and shoulder [7,8]) and simple
counts of the number of pain sites [9,10] have produced conflicting
results. A lack of consistency in case definitions of pain makes it
difficult to compare studies and may explain some of the variation
in findings.
Chronic pain may be a more useful starting point to examine
the relationship between pain and mortality. There is potential for
greater uniformity in case definition with use of recognised criteria
[11]. Chronic pain, that is pain that lasts for three months or
longer [11], is experienced by up to 30% of adults [12] and
commonly occurs in multiple body sites [13]. Widespread pain, a
sub-group of chronic pain and the cardinal symptom of
fibromyalgia is linked with a greater impact than that of pain
that is not widespread [3]. This review focusses on chronic pain,
but additionally examined the relationship between chronic
widespread pain and mortality. Chronic widespread pain is a
phenotype that captures people with more severe pain that has a
greater impact on outcomes [14,15]. We hypothesised that if
chronic pain was associated with mortality that relationship would
be strongest in those with chronic widespread pain.
To determine if chronic pain was associated with mortality, a
systematic review was undertaken. The aims of the review were to
identify and evaluate evidence to determine the strength of
association between chronic pain and mortality, and in particular
in the subgroup of studies investigating chronic widespread pain.
Methods
A protocol for the conduct of this systematic review and meta-
analysis was developed with reference to Centre for Reviews and
Dissemination (CRD) guidelines [16] and consisted of four phases:
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Phase 1: Search strategy and identification of studies
A comprehensive search strategy was conducted by a single
observer (DS). Broad search terms were used to maximise the
identification of all observational studies that have examined the
link between mortality and chronic and/or widespread pain. The
search strategy used subject headings (e.g. MeSH where possible)
and text words for death (e.g. mortality, death, survival), pain (e.g.
musculoskeletal pain, fibromyalgia, joint pain) and study type (e.g.
cohort studies, longitudinal studies and cross-sectional studies) (see
Appendix S1 for full search strategy). The following databases
were searched in March 2012: Ageline, AMED, CINAHL,
EMBASE, MEDLINE, PSYCHINFO, Social Sciences Citation
Index (SSCI) and Science Citation Index Expanded (SCI-
EXPANDED) using ISI Web of Science. The Cochrane databases
(Cochrane Database of Systematic Reviews (Cochrane Reviews)
and the Database of Abstracts of Reviews of Effects (Other
Reviews) (DARE) were searched for relevant reviews. Citation
searches and reference list searches were undertaken to identify
other possible relevant studies. A search of the Open Grey
database for grey literature [17] was undertaken in April 2012 to
identify any relevant papers. Searches in AMED, CINAHL,
EMBASE, MEDLINE and PSYCHINFO were updated until
March 2014.
Phase 2: Study Selection
Identified studies were initially filtered with a title search by a
single observer (DS) based on the following inclusion criteria:
N Study type - observational studies
N Participants – community dwelling adults
N Exposure – chronic (.3months) or widespread pain including
fibromyalgia
N Outcome - mortality
N Papers published in English
A review of abstracts and keywords was then undertaken by two
reviewers (DS) (RW) before the retrieval of full text articles for
further screening. Disagreements were discussed during a consen-
sus meeting with a third reviewer (JM) for final selection of studies
to be included in the review.
Figure 1. Literature search and selection.
doi:10.1371/journal.pone.0099048.g001
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Phase 3: Data Extraction and Quality Assessment
From each included study, data on study population, follow-up
period, pain phenotype, outcome, cause of death and potential
confounding factors, were extracted by one reviewer (DS) and
checked by two others (RW) (JM) for omissions and accuracy
(Table 1). Two reviewers (DS, RW) then used the Quality in
Prognosis Studies tool (QUIPs) [18] to assess for selection, non-
response and information bias and confounding in studies. A third
reviewer (JJ) reviewed selected studies to ensure consistency and
consensus on judgements. Agreement between the two reviewers
was also assessed by actual agreement and by agreement beyond
chance (unweighted Kappa) and these were interpreted as; #
0 = poor agreement, 0.01–0.20 = slight agreement, 0.21–
0.40 = fair agreement, 0.41–0.60 = moderate agreement, 0.61–
0.80 = substantial agreement, and 0.81–1.00 = almost perfect
agreement [19] (Table 2).
Phase 4: Data Synthesis and Analysis
A meta-analysis was conducted to quantify heterogeneity using
the I2 statistic and considered low if less than 25%, moderate if
between 25% and 75% and high if over 75% [20]. To allow for
expected heterogeneity between studies a random effects model
[21] was used which applies less weight to large studies than fixed
effects models [22]. Variation in the definition of chronic pain
(pain phenotype) was expected to be a main source of heteroge-
neity and was therefore explored in a sensitivity analysis, only
including studies using the stricter definition of widespread pain. A
narrative review was undertaken to explore differences and
similarities between included studies for age and gender, follow-
up time, pain phenotype, population characteristics, methods of
analysis and potential confounding factors included. Sources of
heterogeneity are presented and linked to the study findings
descriptively and in tabular form (Table 3).
Crude results were not available for all studies so the meta-
analysis used the maximally adjusted results for each study. Two of
the studies used standardised mortality ratios (SMRs) as their
measures of effect [23,24] and one used adjusted odds ratios
(AORs) [10]. These are not directly comparable to mortality rate
ratios (MRRs) so results from these studies were not included in
the calculation of pooled estimates.
Results
Identification of studies
The search identified 15,057 articles. 15,006 were excluded
during the review of titles as they did not meet the inclusion
criteria (Figure 1). The review of abstracts and keywords resulted
in the exclusion of a further 30 articles. The full texts of 21 articles
were retrieved for further screening and 9 of these were excluded;
for 6 of these studies it was not possible to determine the presence
of widespread pain or chronic pain lasting beyond 3 months
[7,8,25–28], one study was focussed on inpatients in a pain
management clinic [29], one study focussed on disease incidence
as the outcome measure [30] and one examined the relationship
Figure 2. Chronic pain and all-cause mortality (using studies that reported MRR only).
doi:10.1371/journal.pone.0099048.g002
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between lifestyle factors and chronic widespread pain [31]. Twelve
articles describing nine studies remained; three articles were
excluded to avoid using results from the same cohort multiple
times in the analysis [32–34] leaving nine studies for the analysis.
An additional study was added from the automated database
search updates in 2013 [35] resulting in 10 studies for the analysis.
There was wide variation between included studies in terms of
pain phenotype, follow-up time, population characteristics and
inclusion of confounders (Table 1).
Data quality. All ten studies were of good methodological
quality. Reviewers agreed the risk of selection, measurement and
non-response bias was low and the greatest risk of potential bias
was due to deficiencies in inclusion of putative confounders.
Substantial or almost perfect agreement between reviewers
regarding the level of bias was reached for all studies (Kappa
statistic range 0.66 (95%CI 0.47, 0.86) to 0.96 (95%CI 0.88–1.04)
(Table 2).
Study findings. Based on crude, unadjusted analyses one
study reported chronic pain to be associated with mortality MRR
1.32 (95%CI 1.14–1.54) [36] and two studies reported that
widespread pain was associated with all-cause mortality; MRR 2.4
(95%CI 1.9–2.9) [9] and MRR 1.95 (95%CI 1.26–3.03) [37]. In
the first of these studies the association between chronic pain and
mortality was no longer significant following adjustment for age
and sex (MRR 1.15, 95%CI 0.97–1.35) [12]. In the second of
these studies the association remained significant following
adjustment for age, sex, medical practice, ethnic group and
Townsend score of deprivation (MRR 1.3 95%CI 1.1–1.5) [9]. In
the third study, the association remained significant after
adjustment for age and sex (MRR 1.54, 95%CI 1.01–2.35) but
was not significant following adjustment for living alone, contact
with friends, club membership, comorbidity, smoking, physical
activity, BMI, perception of stress and insomnia (MRR 1.09,
95%CI 0.62–1.90) [37]. Macfarlane et al., (2001) did not report
crude results but did report a significant association between
widespread pain and all cause-mortality following adjustment for
age, sex and study location (MRR 1.31, 95%CI 1.05–1.65) [38].
In adjusted analyses Sjøgren et al., (2010) reported a significant
association between chronic pain and mortality (MRR 1.21,
95%CI 1.02–1.44) [39] and where pain was determined to be both
chronic and widespread Nitter and Forseth (2013) reported a
greater increased risk of mortality (MRR 2.80, 95%CI 1.3–6.1).
Dreyer et al (2010) reported borderline significantly increased
mortality in participants with fibromyalgia (SMR 1.25 (95%CI
0.9–1.7) [23]. The remaining three studies did not report
significant or strong associations between chronic or widespread
pain and all-cause mortality [10,24,40].
Evidence synthesis: meta-analysis
Seven of the ten studies used the same outcome measure (MRR)
and were combined to give pooled estimates. For the association
between chronic pain and all-cause mortality, the analysis showed
high statistical heterogeneity (I2 = 78.8%) [20], with MRRs
ranging from 0.86 to 2.80. The pooled estimate was small and
not significant; MRR 1.14 (95%CI 0.95–1.37) (p = 0.162)
(Figure 2). The sensitivity analysis including only studies measuring
widespread pain indicated a slightly higher risk of mortality
although the association was not significant and heterogeneity
Figure 3. Chronic widespread pain and all-cause mortality (using studies that reported MRR only).
doi:10.1371/journal.pone.0099048.g003
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remained high (MRR range 0.86–2.8, I2 82.3%, pooled MRR
1.22 (95%CI 0.93–1.60) (p = 0.157)) (Figure 3).
Eight of the studies provided information regarding cause
specific mortality [9,10,23,24,36–38,40] (Table 1). Five of these
used MRRs and could be combined to provide pooled estimates.
For cancer (Figure 4), the MRRs ranged from 0.64 to 2.07
(I2 = 85.3%), pooled estimate MRR1.20 (95% CI 0.74–1.93)
(p = 0.459). For the sub-group of studies measuring widespread
pain and cancer mortality (Figure 5) MRRs ranged from 0.64–
2.07 (I2 = 87.9%), pooled estimate MRR 1.29 (95% CI 0.70–2.39)
(p = 0.417). For cardiovascular disease mortality (Figure 6), the
MRRs ranged from 0.83 to 2.17 (I2 = 72.5%) pooled estimate
MRR 1.09 (95%CI 0.84–1.41) (p = 0.536). In the widespread pain
subgroup (Figure 7) the MRRs ranged from 0.83 to 2.17
(I2 = 76.8%), pooled estimate MRR 1.17 (95% CI 0.85–1.63)
(p = 0.338). Only four studies provided information about respi-
ratory disease mortality (Figure 8). The effect sizes ranged from
0.89 to 1.23 (I2 = 0.0%), pooled estimate MRR 1.01, (95%CI 0.78
to 1.30) (p = 0.944). For the widespread pain subgroup (Figure 9)
the MRRs ranged from 0.89 to 1.01 (I2 = 0.0%), pooled estimate
MRR 0.97 (95% CI 0.73–1.28) (p = 0.817). Of the studies not
included in the meta-analysis, the only study reporting an
increased risk of mortality from one of these three main causes
of death was Smith et al., (2003) who reported an increased risk of
respiratory disease mortality for women with chronic pain (AOR
2.22, 95%CI 1.1–4.39).
Evidence synthesis: narrative review of potential sources
of heterogeneity
The high heterogeneity between studies may be explained by
the small number of included studies and differences in the age
and gender distribution of study samples, follow-up time, pain
phenotype, population characteristics, methods of analysis and
potential confounding factors included (Table 3).
Age and gender distribution. The age and gender distri-
bution of the study samples varied between studies but there were
no clear differences in the results that could be attributed to this.
The meta-analysis was conducted using results which were
adjusted for age and gender limiting the influence of these factors
on the observed heterogeneity.
Follow up time. Follow up time varied between studies (see
Table 3). The shortest was 6 years [10] and in the longest
participants were followed for up to 35 years [24] but this was not
clearly associated with the differences in findings between studies.
Pain phenotype. All studies measuring widespread pain
reported how closely their phenotype adhered to the criteria
proposed by the American College of Rheumatology (ACR) in
1990, [41] however there were inconsistencies between studies (see
Table 1). The least stringent definition of widespread pain was
applied by Macfarlane et al (2007) who did not find an association
between widespread pain and mortality [40]. In contrast, the three
studies that defined widespread pain similar to the ACR 1990
definition [9,37,38] did report an association between widespread
pain and mortality. Nitter and Forseth (2013) who were able to
Figure 4. Chronic pain and cancer deaths.
doi:10.1371/journal.pone.0099048.g004
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determine chronic widespread pain in all participants reported the
greatest increased risk of mortality in adjusted analyses [35].
Differences in pain phenotype were explored in the sensitivity
analysis in the meta-analysis, where a slight increase in the pooled
estimate was observed when the analysis was restricted to studies
measuring pain that was widespread.
Population characteristics. The study setting is likely to
explain some of the heterogeneity. Four of the studies were carried
out in the UK [9,10,36,38], two in Denmark [23,39], one in
Finland [40], one in Sweden [37], one in Norway [35] and one in
the USA [24]. A greater proportion of the participants in the
Macfarlane et al., (2007) study lived in rural settings [40]
compared to the Macfarlane et al., (2001) and the McBeth et al.,
(2009) studies which although different cohorts, were both carried
out in the same urban area of the UK [9,38]. These two studies in
the urban area reported an increased risk of mortality for people
with widespread pain and an increased risk of cancer mortality
which were not supported by the study in a rural setting [40].
Eight of the studies were carried out in population cohorts
[9,10,35–40] and two were clinical cohorts [23,24]. Both clinical
cohorts reported no significant increased risk of mortality for
fibromyalgia patients.
Inclusion of confounders. There was wide variability in the
type and number of factors adjusted for between studies. Only
three of the studies reported crude results [9,36,37], all indicating
a significant association between chronic or widespread pain and
mortality. It was difficult to determine a clear pattern of how
differences in the factors adjusted for determined variability in the
findings between the studies. Andersson (2009) measured and
adjusted for the highest number of potentially confounding factors
(see Table 3 for details) and concluded their observed increased
risk of mortality for people with widespread pain could be
explained by lifestyle factors such as smoking and physical
activities together with reported stress and disturbed sleep [37].
McBeth et al., (2009), and Nitter and Forseth (2013) did not
include any lifestyle factors in their analyses and the increased risk
of mortality observed in these studies was robust to adjustment of
the factors they included [9,35]. However, Torrance et al., (2010)
reported the association between chronic pain and mortality
attenuated to non-significance following adjustment without
including lifestyle factors [36] (Table 3).
Discussion
Summary of findings
The results of this systematic review and meta-analysis suggest
that there is a modest relationship between chronic pain and
increased mortality but this is not significant. The results also
suggest this relationship may be explained by cancer mortality.
Confidence in these findings is restricted due to the small number
of included studies and heterogeneity between them.
Restricting the analysis to studies measuring widespread pain
and mortality resulted in an increase in the size of the pooled
estimates for all-cause, cancer and cardiovascular disease mortality
but these remained non-significant. Very few studies have
examined the relationship between chronic pain and mortality.
Figure 5. Chronic widespread pain and cancer deaths.
doi:10.1371/journal.pone.0099048.g005
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Only three studies reported crude results, all of which suggested
there was an association between chronic or widespread pain and
an increased rate of all-cause mortality [9,36,37]. However
adjustment for confounders led to attenuation of the relationship.
This suggests that adults with chronic or widespread pain have an
increased mortality rate and this is explained by socio-demo-
graphic and lifestyle factors, however the low number of studies
and high heterogeneity reduces the certainty of this. Significant
associations between chronic or widespread pain and increased
risk of death from cancer, cardiovascular disease, cerebrovascular
disease, liver cirrhosis, suicide, accidents, influenza and pneumo-
nia, septicaemia were reported in single studies.
Differences between studies
The differences between the ten studies led to high levels of
heterogeneity. The study populations differed on a number of
characteristics which will have contributed to the variance in
prevalence rates of widespread pain and mortality, and the
relationship between them.
Definition of chronic or widespread pain. Information
regarding the location of pain was lacking in three of the included
studies so the presence of widespread pain could not be confirmed
although chronic pain often occurs in multiple sites [13]. Similarly,
details regarding the chronicity of pain were not available in all
studies measuring widespread pain but in 80–90% of persons
reporting widespread pain, the pain has been present for more
than three months [38]. Although this means a small proportion of
participants may have been misclassified it would also lead to an
underestimation of the true effect. More rigorous definitions of
widespread pain were more strongly associated with mortality. In
additional analysis, Wolfe et al. (2011) reported that within those
with fibromyalgia, those satisfying the more stringent ACR 2010
criteria [42] had an increased risk of mortality than those who did
not meet the new criteria but met the 1990 criteria (HR1.62,
95%CI 1.19–2.21) [24]. The ACR 2010 criteria extend the scope
of defining widespread pain beyond the location of pain by
including an assessment of the severity of accompanying symptoms
[43]. Increasing severity and duration of pain, in addition to
extent, increases the risk of mortality [36,44]. The revised ACR
2010 criteria, which can be measured using self-report tools in
epidemiological and clinical studies, offers the potential to
harmonise definitions of widespread pain in future studies [43].
Methods of analysis. There were differences in the referent
group between studies which prevented clear comparisons. Eight
studies used participants with no pain as the referent group and
two used standardised populations, one in Denmark [23] and one
in the US [24] which include people both with and without pain.
In an additional analysis, Wolfe and colleagues (2011) compared
mortality rates between fibromyalgia and osteoarthritis patients
and reported no significant difference [24]. Mortality risk is
increased in those with osteoarthritis compared to the general
population [45] therefore this finding is not comparable to the
mortality rate ratios used in other studies. The comparison group
(osteoarthritis patients) cannot be considered analogous to a no
pain group.
Different methods of analysis were used to calculate the
outcome measures (SMR, MRR and AOR) due to variations in
referent groups. Sufficient data were not available to enable
Figure 6. Chronic pain and cardiovascular disease deaths.
doi:10.1371/journal.pone.0099048.g006
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conversion to comparable outcome measures for all studies. The
effects of these different analysis techniques is demonstrated by
McBeth et al (2009), who reported a 30% increased risk of
mortality for people with widespread pain compared to a no pain
group but when compared to the mortality rate for North West
England mortality risk was lower and not significant (SMR = 1.14
95%CI 0.99–1.30) [9]. The more similar the referent group, the
less likely a relationship will be observed. Use of general
population cohorts in which a clear no-pain group can be
identified will allow a purer examination of the link of increased
mortality for those with widespread pain as it would enable
comparison between a group most at risk (those with widespread
pain) with those least at risk (those with no pain).
Follow-up time. Variations in follow-up time between studies
may influence mortality rates although this was not clear from this
review. The mortality rate in those with pain has been shown to be
higher in the earlier periods of follow-up [8]. Jordan et al., (2013)
have also demonstrated the strength of associations between pain
in different musculoskeletal sites and cancer diminished with time
indicating pain may be a marker of rather than a cause of cancer
[46]. However, McBeth et al., (2009) reported no change in the
relationship between widespread pain and both cancer and
cardiovascular death after excluding participants who had died
in the first year of follow up [9]. Standard periods of follow-up,
allowing both short and long term assessment of risk would enable
comparisons between studies and allow a more accurate picture of
the relationship to be determined.
Mechanisms. Differences in study setting may contribute to
variations in factors associated with the presence of pain and
mortality. Pain experienced by those in rural settings may be more
likely to be related to physical labour than those in urban settings
[9], although this may mean they are more physically active.
Physical activity is known to reduce the risk of chronic diseases and
premature death [47]. Clinical and population cohorts will also
have different characteristics of pain, health and socio-demo-
graphic factors. Depending on how healthcare is accessed, the
clinical cohorts may have more severe symptoms and comorbid-
ities compared to general population samples, which will impact
on mechanisms to and rates of mortality. Wolfe and colleagues
(2011) report that the fibromyalgia patients in their study may
have higher socioeconomic status than the general population as
the majority had medical insurance and received care from
specialists rather than general physicians [24]. Higher socioeco-
nomic status and access to care are associated with survival and
may explain why no relationship between fibromyalgia and
mortality was found in these studies [48].
The studies included in this review treated covariates as
confounders and adjusted for them in their analyses. Information
regarding the relative contribution of individual confounders to
the models was not available. However, it may be that these
factors are instead moderating or mediating the relationship
between pain and mortality. Simply adjusting for such factors may
lead to spurious associations between predictor and outcome [49].
Adjustment for confounders in the ten studies, such as age, gender
Figure 7. Chronic widespread pain and cardiovascular disease deaths.
doi:10.1371/journal.pone.0099048.g007
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Figure 8. Chronic pain and respiratory disease deaths.
doi:10.1371/journal.pone.0099048.g008
Figure 9. Chronic widespread pain and respiratory disease deaths.
doi:10.1371/journal.pone.0099048.g009
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and socio-demographic status, indicated that they had a role in the
relationship between widespread pain and mortality. Comparing
similarly adjusted results will control for some of the variance in
the associations between studies due to different population
characteristics (e.g. differences in age and gender distributions).
However differences in how these factors were measured and
classified will have contributed to the heterogeneity. For example,
one study used the Townsend score of deprivation as a measure of
socioeconomic status; this is an area-level measure which is
derived from variables representing unemployment, overcrowding
within households, non-home ownership and lack of car owner-
ship [9]. In contrast the other studies included individual level
measures of socio-economic status, such as educational attainment
and owning medical insurance [24].
There were substantial differences in the number of additional
factors measured and adjusted for between studies (Table 3).
Notably the significant relationship reported in the crude analysis
by Andersson and colleagues (2009) attenuated and was no longer
significant when adjusted for living alone, contact with friends,
club membership, comorbidity, smoking, physical activity, BMI,
perception of stress and insomnia [37] indicating possible
pathways between pain and mortality. Pain is associated with
depression, obesity, a reduction in physical activity [50] and
smoking motivation [51]. Wolfe et al., (2011) found BMI and
smoking to be significant predictors of mortality in a sub-section of
participants [24]. Many of the diseases where increased mortality
was observed have links to lifestyle factors. For example, cancer
and cardiovascular disease are associated with reduced physical
activity [47] and cancer with smoking [52]. A follow up to the
Macfarlane et al., (2001) study using the same cohort reported the
association they observed was with both cancer incidence and
survival; specifically with breast and prostate cancers [34], both of
which have been shown to be associated with physical inactivity
[53,54].
Consideration of potential mechanisms between pain and
mortality with the appropriate designation of mediators and
moderators rather than simple adjustment for confounders would
further the understanding of whether a relationship between pain
and mortality exists and why. Such analysis would enable
potentially modifiable characteristics to be determined that could
be targeted to reduce any identified risk of mortality. There are a
number of potential confounders and mediators that were not
considered in the identified studies in this review which are
associated with both pain and mortality, such as anxiety and
depression [55,56] social participation and social isolation [57,58]
and fatigue [59,60].
Strengths and Limitations
There were a number of strengths in this current study. A
systematic approach was undertaken to maximise the chances of
identifying all relevant studies of chronic pain and mortality. The
quality of the identified studies was assessed using an established
appraisal tool designed to focus on potential bias within studies
[18]. Agreement between reviewers of the risk of bias was high
(Table 2). Study weaknesses include: this review only included
papers that were published in English and it is possible some
relevant findings may have been missed. However a recent search
of CINAHL, Medline and EMBASE did not find any relevant
non-English studies.
The small number of studies (k,20) means that I2 values should
be interpreted with caution as there is little power to detect true
heterogeneity and as such any pooled calculation of effect may be
misleading [61]. A more complex meta-analysis could have been
undertaken to include the studies with multiple follow-ups and
account for the correlation between them. However, even with a
greater number of studies, there is general concern regarding the
appropriateness of the use of meta-analyses in reviews of
observational studies due to the likelihood for high heterogeneity
as a result of difficulties in overcoming selection and confounding
biases common to this type of study [62]. The estimates of pooled
effects calculated in meta-analyses of observational studies are
likely to be flawed and it is therefore more useful to have an
assessment of the potential sources of heterogeneity as the focus of
such systematic reviews (which has been included here) rather than
a statistical combination of the data [63].
Implications for research
This review indicated a modest association between chronic or
widespread pain and increased mortality, particularly cancer
mortality but further research is needed to confirm this. As stated
in a commentary by Crombie (2001) even a small increased risk of
cancer mortality is serious when it applies to a large proportion of
the population [64]. The findings of this systematic review indicate
lifestyle factors may have an important role and these may be
specific to particular conditions [34]. Future research should also
investigate potential mechanisms for a relationship between
widespread pain and mortality directly in large population studies
where specific mediators and moderators can be assessed using
appropriate statistical methods. Attention should also be given to
previously unmeasured social, physiological and psychological
factors. The identification of pathways between pain and mortality
would facilitate the identification of individuals at risk.
Conclusions
Following this systematic review, a modest but non-significant
relationship between chronic pain and mortality is suggested,
particularly cancer mortality. Harmonised data collection, consis-
tent pain phenotypes, sample populations and methods of analyses
are required to robustly determine whether chronic pain increases
the risk of mortality, and if so to identify the pathways by which
this occurs. This combined with an investigation of the role of
health, lifestyle, social and psychological factors could provide a
clearer picture of the relationship between chronic pain and
mortality.
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